Prophylactic mastectomy and occult cancer: a ten-year experience at a cancer center

被引:2
|
作者
Mangiardi-Veltin, Manon [1 ]
Chamming's, Foucauld [2 ]
Jaffre, Anne [3 ]
Rousvoal, Aurelien [4 ]
de Lara, Christine Tunon [4 ]
Brouste, Veronique [5 ]
Hoppe, Stephanie [5 ]
Senechal, Claire [6 ]
机构
[1] Univ Bordeaux, F-33000 Bordeaux, France
[2] Inst Lutte Canc, Inst Bergonie, Serv Imagerie Med, F-33000 Bordeaux, France
[3] Inst Lutte Canc, Inst Bergonie, Dept Informat Med, F-33000 Bordeaux, France
[4] Inst Lutte Canc, Inst Bergonie, Serv Chirurg, F-33000 Bordeaux, France
[5] Inst Lutte Canc, Inst Bergonie, Serv Biostat, F-33000 Bordeaux, France
[6] Inst Lutte Canc, Inst Bergonie, Serv Oncogenet, 229 Cours Argonne, F-33000 Bordeaux, France
关键词
Breast cancer; Prophylactic surgery; BRCA mutation; Complication; Reoperation; Occult cancer; REDUCTION;
D O I
10.1016/j.bulcan.2021.05.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction > Women identified as high-risk for breast cancer may choose between close followup and radical mastectomy. Prophylactic mastectomy, as any other surgery, is associated with benefits and harms. The aim of this study was to assess the morbidity associated with prophylactic mastectomy and to evaluate the prevalence of occult cancers. Methods > All patients who underwent unilateral or bilateral prophylactic mastectomy between 2007 and 2017 in our institution were eligible for inclusion in this retrospective study. Medical history, type of surgery, occurrence of complication or reoperation and pathological reports were examined in medical charts. Results > 79 women underwent prophylactic mastectomy over the studied period of which 58.2% were contralateral after breast cancer. A genetic mutation was present in 86.1% of cases. Postoperative complications occurred in 43.0% of cases. An additional surgery for medical or esthetic purpose was needed in 72.1% of cases. Occult cancer was found in 11.4% of the pathological reports. Triple negative invasive ductal carcinoma was discovered in two cases (2.5%). Discussion > Prophylactic mastectomy is the only effective preventive action against breast cancer. Women must be clearly informed of possible complications, high reoperation rate and potential pathological findings. Identifying women most at risk for breast cancer would help to better target those who will benefit most from surgery.
引用
收藏
页码:999 / 1009
页数:11
相关论文
共 50 条
  • [1] Ten-year experience of bone SBRT in breast cancer: analysis of predictive factors of effectiveness
    Perez-Montero, Hector
    Lozano, Alicia
    de Blas, Rodolfo
    Sanchez, Juan Jose
    Martinez, Evelyn
    Laplana, Maria
    Gil-Gil, Miguel
    Garcia-Tejedor, Amparo
    Pernas, Sonia
    Falo, Catalina
    Godino, Oscar
    Pla, Maria J.
    Guedea, Ferran
    Navarro-Martin, Arturo
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (06) : 1756 - 1766
  • [2] Ten-year experience of bone SBRT in breast cancer: analysis of predictive factors of effectiveness
    Héctor Pérez-Montero
    Alicia Lozano
    Rodolfo de Blas
    Juan José Sánchez
    Evelyn Martínez
    María Laplana
    Miguel Gil-Gil
    Amparo Garcia-Tejedor
    Sonia Pernas
    Catalina Falo
    Óscar Godino
    Maria J. Pla
    Ferrán Guedea
    Arturo Navarro-Martin
    Clinical and Translational Oncology, 2023, 25 : 1756 - 1766
  • [3] Breast-conserving therapy versus mastectomy for breast cancer: a ten-year follow-up single-center real-world study
    Li, Wanheng
    Zheng, Yiqiong
    Wu, Huan
    Li, Xiru
    GLAND SURGERY, 2022, 11 (07) : 1148 - 1165
  • [4] Trends in mastectomy and reconstruction for breast cancer; a twelve year experience from a tertiary care center
    Chang, James M.
    Kosiorek, Heidi E.
    Dueck, Amylou C.
    Casey, William J.
    Rebecca, Alanna M.
    Mahabir, Raman
    Patel, Samir H.
    Keole, Sameer R.
    Wong, William W.
    Vargas, Carlos E.
    Halyard, Michele Y.
    Gray, Richard J.
    Wasif, Nabil
    Stucky, Chee-Chee H.
    Pockaj, Barbara A.
    AMERICAN JOURNAL OF SURGERY, 2016, 212 (06) : 1201 - 1210
  • [5] Occult primary breast cancer at a comprehensive cancer center
    Fayanju, Oluwadamilola M.
    Jeffe, Donna B.
    Margenthaler, Julie A.
    JOURNAL OF SURGICAL RESEARCH, 2013, 185 (02) : 684 - 689
  • [6] Predictors for contralateral prophylactic mastectomy in breast cancer patients
    Fu, Yun
    Zhuang, Zhigang
    Dewing, Michelle
    Apple, Sophia
    Chang, Helena
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (04): : 3748 - 3764
  • [7] Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: Ten-year audit of single centre experience
    Mike G. Bourke
    Slav P. Salwa
    Mira Sadadcharam
    Maria C. Whelan
    Patrick F. Forde
    John O. Larkin
    Chris G. Collins
    Seamus O’Reilly
    Gerald C. O’Sullivan
    A. James Clover
    Declan M. Soden
    Breast Cancer Research and Treatment, 2017, 161 : 289 - 297
  • [8] Videolaparoscopic Radical Hysterectomy Approach: a Ten-Year Experience
    Campos, Luciana Silveira
    Limberger, Leo Francisco
    Kalil, Antonio Nocchi
    de Vargas, Gabriel Sebastiao
    Damiani, Paulo Agostinho
    Haas, Fernanda Feltrin
    JSLS-JOURNAL OF THE SOCIETY OF LAPAROENDOSCOPIC SURGEONS, 2009, 13 (04) : 504 - 508
  • [9] Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: Ten-year audit of single centre experience
    Bourke, Mike G.
    Salwa, Slav P.
    Sadadcharam, Mira
    Whelan, Maria C.
    Forde, Patrick F.
    Larkin, John O.
    Collins, Chris G.
    O'Reilly, Seamus
    O'Sullivan, Gerald C.
    Clover, A. James
    Soden, Declan M.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (02) : 289 - 297
  • [10] Incidence of primary breast cancer in Iran: Ten-year national cancer registry data report
    Jazayeri, Seyed Behzad
    Saadat, Soheil
    Ramezani, Rashid
    Kaviani, Ahmad
    CANCER EPIDEMIOLOGY, 2015, 39 (04) : 519 - 527